Related Experiment Video
Updated: Aug 27, 2025
12:24
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
10.0K
COVID-19 vaccine-associated myocarditis
Michael C Morgan1, Lavannya Atri2, Sean Harrell2
1Division of Cardiology, Medical College of Georgia, Augusta, GA 30912, United States. mimorgan@augusta.edu.
World Journal of Cardiology
|September 26, 2022
Summary
Myocarditis is a rare complication of COVID-19 mRNA vaccination, especially in young males. Most cases resolve quickly, but further research is needed on long-term outcomes.
Area of Science:
- Immunology
- Cardiology
- Vaccinology
Background:
- Myocarditis is a rare adverse event following COVID-19 mRNA vaccination.
- Adolescent and young adult males are disproportionately affected.
- Reported cases show symptoms like chest pain and elevated troponin levels.
Purpose of the Study:
- To review the incidence, clinical presentation, and proposed mechanisms of COVID-19 vaccine-mediated myocarditis.
- To discuss potential reasons for higher incidence in young males.
- To highlight the need for further research on long-term outcomes.
Main Methods:
- Analysis of reported cases from CDC surveillance data.
- Review of clinical presentations and diagnostic markers.
- Exploration of proposed pathophysiological mechanisms.
Main Results:
- Over 1175 confirmed cases reported in individuals 30 years and younger by January 2022.
- Estimated incidence of 40.6 cases per million second doses in males aged 12-29.
- Most cases exhibit a benign clinical course with rapid symptom resolution.
Conclusions:
- COVID-19 mRNA vaccines are associated with rare myocarditis, primarily in young males.
- Potential mechanisms involve molecular mimicry and immune dysregulation.
- Continued vaccination is recommended due to higher risks from natural infection, but long-term outcomes require further investigation.
Related Concept Videos
01:14Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
01:21Myocarditis I: Introduction
23
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
01:27Myocarditis II: Clinical Features and Diagnostic Tests
19
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
01:22Myocarditis IV: Nursing Management
17
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
21
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21
01:25Cardiomyopathy I: Introduction and Classification
41
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41